Both in Lab Analytical Instruments
10x Genomics vs Illumina
Over the past year TXG returned +411.8% and ILMN returned +96.7%; their daily moves had a correlation of 0.55.
TXG +411.8% ILMN +96.7%Growth of $1, one year, split-adjusted
| Metric | TXG | ILMN |
|---|---|---|
| Price | $70.11 | $235.99 |
| Market cap | $9.13B | $35.63B |
| Today | −14.03% | −18.64% |
| 1 month | −21.0% | −11.2% |
| 6 months | +212.6% | +73.8% |
| Year to date | +329.9% | +79.9% |
| 1 year | +443.5% | +148.3% |
| Revenue growth (YoY) | −12.6% | +4.2% |
| Gross margin | 74.5% | 73.5% |
| Net margin | −11.9% | 19.5% |
| P/E (TTM) | — | 39.8× |
| Price / sales | 14.8× | 7.9× |
| Net cash | $552.0M | -$452.0M |
| Dividend yield | — | — |
| Volatility (60d) | 87.8% | 66.6% |
| Short % of float | 10.9% | 5.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).